摘要
目的观察生麦芽联合芒硝在中期妊娠引产后回奶中的临床疗效与安全性。方法中期妊娠引产需回奶的患者共120例,随机分为3组:第1组产后当日服用生麦芽60g+300mL水煎当茶饮,1剂/d,连服5d并于产后第2天予芒硝250g,分装入2个纱布袋中,均匀地敷于两乳房并包扎,湿硬时更换,连续使用5 d。第2组患者口服甲磺酸溴隐亭2.5 mg,早晚各1次,连服5 d。第3组口服戊酸雌二醇5 mg,3次/d,连服3d。观察5 d后3组产妇的回奶效果及安全性。结果甲磺酸溴隐亭组回奶效果为90%,戊酸雌二醇组为80%,而生麦芽联合芒硝组为100%。生麦芽联合芒硝组与其他2组比较,差异有统计学意义(P<0.05)。结论生麦芽联合芒硝的回奶效果较好,且副作用较小。
Objective To observe the clinical efficacy and safety of raw malt combined with mirabilite for delactation in patients with midtrimester pregnancy odinopoeia. Methods 120 midtrimester pregnancy odinopoeia patients in need of delactation were randomly divided into three groups. The first group received decocted raw malt 60 g + 300 mL as tea drink in postpartum day, 1 agent/day for 5 days, and then took mirabilite 250 g in the second day after parturition. Mirabilite was packaged into two gauze bags and evenly applied and bound on the two breasts. Re- placing drugs when the two gauze bags became wet and hard, and this mirabilite treatment contin- ued for 5 days. The second group received bromocriptine mesilate 2.5 mg twice per day (in the morning and evening) for 5 days. The third group received oral estradiol valerate 5 mg 3 times per day for 3 days. After 5 days, delactation effect and safety among three groups were observed. Re- sults Delactation effects of three groups were 90% (bromocriptine mesilate group), 80% (estradi- ol valerate group) and 100 % (raw malt combined with mirabilite group). There was statistical sig- nificance between raw malt combined with mirabilite group and the other two groups ( P 〈 0.05). Conclusion Raw malt combined with mirabilite therapy is effective for delactation and its side ef- fect is small as well.
出处
《实用临床医药杂志》
CAS
2012年第20期77-78,共2页
Journal of Clinical Medicine in Practice
关键词
生麦芽
芒硝
引产后回奶
观察
护理
raw malt
mirabilite
delactation after odinopoeia
observation
nursing